Skip to site content

2023 Catalog: General Courses

To view other courses in this category, use the “Previous” and “Next” buttons. To select this course and request approval, please login. Need more help reading this page?



DE0792: Diabetes Online CDE: Management of Type 2 Diabetes: An Update and Review of Non-Injectable Pharmacological Treatment

 
Date: 5/03/2023 - 5/02/2026
Course Status: Available
Facility: Online
Location: Online
Instructor: Richard Arakaki
Director: Wendy Castle
Level: Basic
Audience: Assistants, Dentists, DHA, Hygienists
Quota: 1 - 1000 students
Tuition: $0.00
Hours: 1.00 (Total CDE); 1.00 (DANB Non-Clinical); 1.00 (AGD - 149)
Joint Sponsorship: No
Lecture icon Question and Answer icon
Summary:

The prevalence of diabetes among the diverse adult US population approximate 11.3 with the highest rate in AI/AN of 14.5. Encouragingly, the incidence rates of newly diagnosed diabetes and diabetes-related complications has decreased in the past 2 decades. New clinical trial evidence has shaped the treatment of hyperglycemia and complications with oral agents in patients with type 2 diabetes.

Learning Objectives:

Upon completion of this course, participants will be able to:
1. Identify the prevalence and burden of diabetes mellitus across the country, specifically among AI/AN communities
2. Discuss the current non-injectable pharmacologic treatment of hyperglycemia and complications mitigation
3. Implement the standards of care for the management of patients with diabetes



Speaker / Presenter:

Richard Arakaki — For follow-up questions, please contact the speaker at Richard.arakaki@ihs.gov.

Disclosure Policy:

It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.

None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.

Accreditation:
The IHS Division of Oral Health is an ADA CERP Recognized Provider

The IHS Division of Oral Health is an accredited sponsor of continuing education under the American Dental Association Continuing Education Recognition Program (CERP). ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the IHS at IHS CDE Coordinator or to the Commission for Continuing Education Provider Recognition at CCEPR.ada.org

Prerequisites:

None

Tuition Payment Information:

NA

Tuition Policy:

Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.